Machine Learning-Optimized Digital Therapy for Emotional Disorders
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial aims to improve digital mental health treatments for Kaiser Permanente members by using machine learning to recommend the best program for each person. Participants will be placed in one of three online mental health programs and receive ongoing support. The goal is to find out which program works best for different people.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications. It seems focused on digital mental health interventions, so it's likely you can continue your current treatments, but you should confirm with the trial organizers.
Is the Machine Learning-Optimized Digital Therapy for Emotional Disorders generally safe for humans?
How is the Machine Learning-Optimized Digital Therapy for Emotional Disorders treatment different from other treatments for depression?
This treatment is unique because it uses machine learning to predict how well a person will respond to digital interventions, allowing for personalized treatment plans. It combines digital tools like online therapy and virtual reality with traditional methods, making it more accessible and engaging for patients.678910
What data supports the effectiveness of this treatment for emotional disorders?
Digital mental health interventions, like internet-based cognitive behavioral therapy (iCBT), have shown effectiveness in reducing symptoms of depression and anxiety. In one study, patients using a digital mental health program experienced a 23% reduction in depression scores, indicating potential benefits for emotional disorders.911121314
Are You a Good Fit for This Trial?
This trial is for English-speaking adults aged 18 or older who have access to an internet-connected device. It's designed for those experiencing emotional disorders like anxiety and depression.Inclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Baseline Assessment
Participants complete baseline assessment questionnaires through Qualtrics
Treatment
Participants are randomly assigned to one of three digital mental health interventions and receive regular asynchronous support
Follow-up
Participants are monitored for changes in well-being, anxiety, and depression
What Are the Treatments Tested in This Trial?
Interventions
- Digital Interventions
- Space for depression
- Space for resilience
- The Unified Protocol for Transdiagnostic Treatment of Emotional Disorders (UP)
Digital Interventions is already approved in European Union, United States, Canada for the following indications:
- Anxiety Disorders
- Depressive Disorders
- Trauma and Stressor-Related Disorders
- Major Depressive Disorder
- Generalized Anxiety Disorder
- Post-Traumatic Stress Disorder
- Mood Disorders
- Anxiety Disorders
- Substance Use Disorders
Find a Clinic Near You
Who Is Running the Clinical Trial?
Boston University Charles River Campus
Lead Sponsor
National Institute of Mental Health (NIMH)
Collaborator
Silver Cloud Health
Collaborator
Kaiser Permanente
Collaborator